by simultaneously enhancing antioxidant capacity, inhibiting ROS-generating pathways, and improving mitochondrial resilience (175177), exerkines may overcome the inherent limitations of single-agent antioxidant strategies and offer a more durable therapeutic approach for DR

Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced

For quality control, we excluded participants who (1) have excess relatedness (more than 10 putative third-degree relatives), (2) have inconsistent information about sex based on genotyping and self-report, (3) have sex-chromosomes not XX or XY, (4) have poor-quality genotyping based on heterozygosity and missing rates, or (5) have withdrawn from UK Biobank
According to Gigliotti, [Weight management medications] can make eating healthier easier because people may experience fewer cravings and less temptation to overeat. Share that stopping weight management drugs can result in weight regain
Fasting insulin levels were elevated in SKO mice when compared to WT controls but to a similar extent between vehicle- and liraglutide-treated groups ( Figure 4G
When combined with exercise and a healthy diet, they have been life-changing for many people with obesity and/or type 2 diabetes